Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fucosyltransferase 8 (FUT8) is a mammalian enzyme responsible for the addition of fucose in an α1,6 linkage to the innermost N-acetylglucosamine (GlcNAc) residue of N-linked glycans, a process known as core fucosylation. This unique modification is essential for protein maturation, modulating the function of receptors like TGF-β, EGF, and IgG Fc, thereby impacting cell signaling, adhesion, immune response, and development. FUT8 is critically involved in cancer progression and is explored as a target for glycoengineering in antibody therapeutics to increase immune-mediated cytotoxicity. Loss of FUT8 function is associated with lethal developmental phenotypes and impaired organogenesis.
Inhibition: Blockade of FUT8 activity prevents core fucosylation, enhances therapeutic antibody binding to Fcγ receptors, and increases immune effector function. Gene knockout or editing: Used in cell lines to produce afucosylated biotherapeutics with increased efficacy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fucosyltransferase 8 (FUT8).